Skip to content
Screener

Twist Bioscience Corporation TWST Investing Cash Flow

Investing Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$164M+157%
Danaher logo
DanaherDHR
-$10.15B-3,833%
Azenta logo
AzentaAZTA
-$114.75M+17.3%
Agilent Technologies logo
Agilent TechnologiesA
-$77M+32.5%
Illumina logo
IlluminaILMN
-$121M-147%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$25.08M-416%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands)Six months ended March 31, 2026Six months ended March 31, 2025
Proceeds from maturity of investments25,55028,975
Cash paid for asset acquisition(5,000)—
Cash paid for investment in equity securities(1)—
Net cash used in investing activities$(22,639)$(2,962)
Financing activities
Proceeds from exercise of stock options$2,089$3,722
Proceeds from the issuance of liability related to sale of future revenue—15,000
Proceeds from issuance under employee stock purchase plan2,3572,429

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's investing cash flow?
Twist Bioscience Corporation (TWST) reported investing cash flow of -$12.71M in Q1 2026.
How has Twist Bioscience Corporation's investing cash flow changed year-over-year?
Twist Bioscience Corporation's investing cash flow decreased by 791.0% year-over-year, from -$1.43M to -$12.71M.
What is the long-term trend for Twist Bioscience Corporation's investing cash flow?
Over 3 years (2021 to 2025), Twist Bioscience Corporation's investing cash flow has grown at a -45.9% compound annual growth rate (CAGR), from $156.16M to -$24.76M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Twist Bioscience Corporation's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude